Hydromorphone - Hospira

Drug Profile

Hydromorphone - Hospira

Alternative Names: Hydromorphone hydrochloride - Hospira

Latest Information Update: 14 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Hospira
  • Class Morphine derivatives; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preregistration Pain

Most Recent Events

  • 03 Sep 2015 Hospira has been acquired by Pfizer
  • 20 Jul 2015 The tentatively approved label for hydromorphone hydrochloride injection carries a black box warning
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top